Birgit Lackner1, Gerald Schmidinger, Christian Skorpik. 1. Department of Ophthalmology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. birgit.lackner@meduniwien.ac.at
Abstract
PURPOSE: The purpose of this study was to determine the validity and repeatability of anterior chamber depth (ACD) measurements obtained with a novel rotating Scheimpflug camera (Pentacam; Oculus Optikgeräte GmbH, Wetzlar, Germany) to scanning slit topography (Orbscan; Bausch & Lomb, Rochester, NY). METHODS: ACD in 60 healthy eyes was measured twice by two independent observers with each modality in random order. A total of eight measurements was performed on each eye. The mean differences between measurements, between observers, and between modalities were calculated, and 95% limits of agreement (LoA) were given as mean +/- 1.96 * standard deviation (SD) of the mean. RESULTS: The mean ACD values as determined with the different modalities (+/- SD) were 3.18 +/- 0.38 mm for Pentacam imaging and 3.23 +/- 0.40 for Orbscan. The mean difference between the two modalities was 0.047 mm (LoA: 0.176 to -0.081 mm). Within each modality, the limits of agreement of the differences between individual measurements and between different observers were within 0.073 mm or 4% of total ACD. The total variance in the observed data was 0.145. The variance resulting from interindividual differences in ACD was 85%, as a result of the two different modalities 15%, as a result of different observers 0.007%, and as a result of different measurements 0.007%. CONCLUSIONS: In the assessment of normal eyes, the differences of ACD values measured with Orbscan and Pentacam were within clinically acceptable levels, and inter- and intraobserver variability was considerably below clinically significant levels. Thus, these two modalities can be regarded as interchangeable.
PURPOSE: The purpose of this study was to determine the validity and repeatability of anterior chamber depth (ACD) measurements obtained with a novel rotating Scheimpflug camera (Pentacam; Oculus Optikgeräte GmbH, Wetzlar, Germany) to scanning slit topography (Orbscan; Bausch & Lomb, Rochester, NY). METHODS: ACD in 60 healthy eyes was measured twice by two independent observers with each modality in random order. A total of eight measurements was performed on each eye. The mean differences between measurements, between observers, and between modalities were calculated, and 95% limits of agreement (LoA) were given as mean +/- 1.96 * standard deviation (SD) of the mean. RESULTS: The mean ACD values as determined with the different modalities (+/- SD) were 3.18 +/- 0.38 mm for Pentacam imaging and 3.23 +/- 0.40 for Orbscan. The mean difference between the two modalities was 0.047 mm (LoA: 0.176 to -0.081 mm). Within each modality, the limits of agreement of the differences between individual measurements and between different observers were within 0.073 mm or 4% of total ACD. The total variance in the observed data was 0.145. The variance resulting from interindividual differences in ACD was 85%, as a result of the two different modalities 15%, as a result of different observers 0.007%, and as a result of different measurements 0.007%. CONCLUSIONS: In the assessment of normal eyes, the differences of ACD values measured with Orbscan and Pentacam were within clinically acceptable levels, and inter- and intraobserver variability was considerably below clinically significant levels. Thus, these two modalities can be regarded as interchangeable.
Authors: Mohammad Soleimani; Hassan Hashemi; Shiva Mehravaran; Mehdi Khabazkhoob; Mohammad Hassan Emamian; Mohammad Shariati; Akbar Fotouhi Journal: Int J Ophthalmol Date: 2013-08-18 Impact factor: 1.779
Authors: Matthew T Feng; Michael W Belin; Renato Ambrósio; Satinder P S Grewal; Wang Yan; Mohamed S Shaheen; Charles McGhee; Naoyuki Maeda; Tobias H Neuhann; H Burkhard Dick; Saleh A Alageel; Andreas Steinmueller Journal: Saudi J Ophthalmol Date: 2011-04-30
Authors: Muriël Doors; Lars P J Cruysberg; Tos T J M Berendschot; John de Brabander; Frenne Verbakel; Carroll A B Webers; Rudy M M A Nuijts Journal: Graefes Arch Clin Exp Ophthalmol Date: 2009-04-30 Impact factor: 3.117